Cargando…
LINC00941 promotes glycolysis in pancreatic cancer by modulating the Hippo pathway
Pancreatic ductal adenocarcinoma (PDAC) is one of most lethal cancers and is projected to be the second leading cause of cancer deaths in the United States by 2030. The lack of effective treatment and increased incidence in PDAC encourage a deeper knowledge of PDAC progression. By analyzing a long n...
Autores principales: | Xu, Ming, Cui, Ran, Ye, Lunhe, Wang, Yongkun, Wang, Xujing, Zhang, Qiqi, Wang, Kaijing, Dong, Chunxiu, Le, Wenjun, Chen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413680/ https://www.ncbi.nlm.nih.gov/pubmed/34513310 http://dx.doi.org/10.1016/j.omtn.2021.07.004 |
Ejemplares similares
-
LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway
por: Li, Zhihai, et al.
Publicado: (2022) -
LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2
por: Wang, Jie, et al.
Publicado: (2022) -
Expression changes of serum LINC00941 and LINC00514 in HBV infection‐related liver diseases and their potential application values
por: Chen, Juanjuan, et al.
Publicado: (2021) -
Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma
por: Lu, Jun-Tao, et al.
Publicado: (2023) -
LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway
por: Lin, Xueke, et al.
Publicado: (2020)